Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
GDRX Transcript
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Positive5-8
The earnings call summary and Q&A indicate strong growth in Pharma Direct and condition-specific subscriptions, with optimistic guidance for 2026. Despite some uncertainties in partnerships and PTR revenue, the overall sentiment is positive due to expected revenue and EBITDA growth, as well as strong demand for GLP-1 therapies. The market cap suggests moderate stock price reaction, leading to a 'Positive' prediction (2% to 8%).
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call reveals strong growth prospects, including a 35% YoY increase in Manufacturer Solutions revenue and strategic investments in e-commerce and subscriptions, despite a slight revenue decline due to timing. Positive trends in Pharma Direct and increasing web traffic, alongside durable partnerships, indicate optimism. However, margin pressures and lower take rates are concerns, but the overall sentiment remains positive due to the company's strategic direction and market expansion efforts. The market cap suggests moderate stock volatility, aligning with a positive prediction.
GoodRx Holdings, Inc. (GDRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call summary and Q&A indicate strong growth prospects, particularly in manufacturer solutions and strategic initiatives, despite some headwinds like Rite Aid bankruptcy. The positive sentiment is reinforced by management's optimistic guidance and strategic focus on market expansion and partnerships. The market cap suggests a moderate reaction, leading to a 'Positive' prediction for stock price movement.
GDRX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
